Health Trials

High-risk (Secondary) Acute Myeloid Leukemia

1

Review clinical trials related to High-risk (Secondary) Acute Myeloid Leukemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

The purpose of this bridging study is to determine the efficacy of liposomal cytarabine-daunorubicin for injection compared with cytarabine and daunorubicin in older patients with high-risk (secondary) acute myeloid leukemia.

Participants needed: 120
Trial details
Phase: Phase 3Age: 60-75Biological sex: AllType: InterventionalSponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Updated: Dec 28, 2023Locations: 1
Eligibility criteria

Able to understand the study and voluntarily sign informed consent. [+12]

Acute promyelocytic leukemia; or favorable cytogenetics, including t(8;21) or in... [+16]

Read more